A detailed history of Ea Series Trust transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Ea Series Trust holds 183,977 shares of DVAX stock, worth $2.36 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
183,977
Holding current value
$2.36 Million
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$9.85 - $13.17 $1.81 Million - $2.42 Million
183,977 New
183,977 $2.38 Billion

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Ea Series Trust Portfolio

Follow Ea Series Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ea Series Trust, based on Form 13F filings with the SEC.

News

Stay updated on Ea Series Trust with notifications on news.